“MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS” (2023) Mediterranean Journal of Hematology and Infectious Diseases, 15(1), p. e2023047. doi:10.4084/MJHID.2023.047.